AI-Prognosis: Artificial intelligence-based Parkinson's disease risk assessment and prognosis

Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, affecting ~10 million people worldwide, and this number is projected to almost double by the year 2040.

PD is often missed or misdiagnosed, as early symptoms are subtle and common with other diseases. Effective, symptomatic treatments are available, yet selecting the optimal regimen is usually a lengthy, “trial and error” process, leading to unnecessary suffering. Overall costs to Europe have been estimated at ~€13.9 billion annually, with the cost per patient increasing with severity.

With the AI-PROGNOSIS project, we aim to advance Parkinson’s disease diagnosis and care through novel predictive models combined with digital biomarkers from everyday devices.